摘要
2019年底由新型冠状病毒(SARS-CoV-2)引起的肺炎已构成全球公共卫生的重大威胁,我国政府采取高强度的防控措施使疫情得到有效控制,但世界疫情仍处于大爆发期,我国目前正面临病例输入性的威胁。实验室检查(以核酸检测为主)是新型冠状病毒感染病例筛查、早期诊断和疗效评价的重要手段之一。然而,实验室生物安全防护是检验检查者安全防护的重要防线,疫情期间,我院检验科实施了一系列防护措施,最大程度的规范了检验检查和防控流程,有效降低了检验科医务人员院内感染的风险。
Pneumonia caused by the 2019 novel coronavirus(SARS-CoV-2)has broken out in China since the end of 2019.Although the epidemic situation in China has been effectively brought under control,the world is still in an outbreak phase,and China is now facing the threat of imported cases.Laboratory testing(mainly nucleic acid detection)is one of the important methods for screening,early diagnosis and efficacy evaluation of new cases of coronavirus infection.However,laboratory biosafety protection is an important line of defense for inspectors and inspectors.During the epidemic,the inspection department of our hospital implemented a series of protective measures to standardize the inspection and inspection and prevention and control processes to the greatest extent,reducing the medical staff in the inspection department risk of nosocomial infection effectively.
作者
朱名超
朱娅
Zhu Mingchao;Zhu Ya(Department of Clinical Laboratory,The First People′s Hospital of Tianmen,Tianmen Hubei 431700,China;Department of Neurology,The First People′s Hospital of Tianmen,Tianmen Hubei 431700,China.)
出处
《中华临床实验室管理电子杂志》
2020年第3期186-191,共6页
Chinese Journal of Clinical Laboratory Management(Electronic Edition）
